Fiscal Year 2007 - Department of Medicine - University of ...

Recommendations

Info

Sponsor and Title: Janssen Medical Affairs, LLC, “Strain Typing of Clinical Pseudmonase Aeruginos Isolate by VNTR” Principal Investigator: Edwin Swiatlo Project Period: 03/01/2006-02/28/2008 Annual Funding: $6,000 Sponsor and Title: Cubist Pharmaceuticals, “Treatment of Indwelling Vascular Graft Infection with Daptomycin in a Rat Model” Principal Investigator: Edwin Swiatlo Project Period: 10/01/2005-09/30/2007 Annual Funding: $12,000 Sponsor and Title: NHLBI, “Jackson Heart Study” Principal Investigator: Herman A. Taylor, Jr. Project Period: 06/01/1999-05/31/2013 Annual Funding: $9,900,491 Sponsor and Title: NHLBI, “Hypertension Education and Treatment (HEAT) Partnership” Principal Investigator: Herman A. Taylor, Jr. Project Period: 09/30/2004-09/29/2009 Annual Funding: $541,845 Sponsor and Title: NIH, “Excellence in Partnerships for Community Outreach, Research on Health Disparities and Training” Principal Investigator: Herman A. Taylor, Jr. Project Period: 09/30/2004-09/29/2009 Annual Funding: $236,551 Sponsor and Title: HHS, “National Cancer Prevention and Control Center” Principal Investigator: James T. Thigpen Project Period: 10/01/2004-09/30/2006 Annual Funding: $936,498 Sponsor and Title: Mississippi State Department of Health, “Mississippi Cancer Registry” Principal Investigator: James T. Thigpen Project Period: 10/01/2004-09/30/2006 Annual Funding: $123,895 Sponsor and Title: Centers for Disease Control and Prevention, “Mississippi Cancer Registry – NPCR” Principal Investigator: James T. Thigpen Project Period: 06/30/2007-06/29/2012 Annual Funding: $783,216 Sponsor and Title: Millennium Pharmaceuticals, “A Multi-center, Open-Label, Phase 2 Study of VELCADE, for Injection in Previously Treated Patients with Stage IIIB and IV Bronchioalveolar Carcinoma and Adenocarcinoma and Bronchioloalveolar” Principal Investigator: Ralph Vance Project Period: 10/01/2005-09/30/2007 Annual Funding: $76,034 Sponsor and Title: American Cancer Society, “Characterization of T-3 and RA-responsive Genes potentially involved in the Pathogenesis of Hepatocellular Carcinoma” Principal Investigator: Tereza Ventura-Holman Project Period: 03/1/2007-02/29/2008 Annual Funding: $30,000 Sponsor and Title: NIH, “Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study” Principal Investigator: James G. Wilson Project Period: 04/01/2006-3/31/2010 Annual Funding: $748,233 Sponsor and Title: Alexion Pharmaceuticals, Procter & Gamble Pharmacy, “APEX-AMI: A Multi-center, Randomized, Double-blind, Parallelgroup, Placebo-group, Placebo-controlled Study of Pexelizumab in Patients with Acute Myocaridal Infarction Undergoing Primary Percutaneous Coronary Intervention” Principal Investigator: Michael Winniford Project Period: 12/01/2006-11/30/2007 Annual Funding: $4,625 77
78 Sponsor and Title: Robert Wood Johnson Foundation, “Expecting Success: Excellence in Cardiac Care through Improving the Continuum of Care for Minority Patients” Principal Investigator: Michael Winniford Project Period: 09/15/2005-02/14/2008 Annual Funding: $199,298 Sponsor and Title: Robert Wood Johnson Foundation, “Improving Heart Care using the Patient Activation Measure and Customized Patient Support” Principal Investigator: Michael Winniford Project Period: 12/01/2006-11/30/2008 Annual Funding: $8,295 Sponsor and Title: Novaris Pharmaceuticals, “A Randomized, Double-Blind, Placebo-Controlled, Multi-center Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance” (NAVIGATOR) Principal Investigator: Marion R. Wofford Project Period: 12/01/2002-12/31/2009 Annual Funding: $107,972 Sponsor and Title: NHLBI, “Clinical Trial of Dietary Protein on Blood Pressure” Principal Investigator: Marion R. Wofford Project Period: 07/01/2004-06/30/2007 Annual Funding: $1,109,287 Sponsor and Title: Mylan/Bertek Pharmaceuticals, “ A Double-Blind, Randomized, Placebo-and Active-Controlled, Forced Titration Study Evaluating the Effects of Nevivolol on Blood Pressure and Heart Rate in African American Patients with Hypertension” Principal Investigator: Marion R. Wofford Project Period: 04/01/2005-12/01/2006 Annual Funding: $43,601 Sponsor and Title: Novartis Pharmaceuticals, “A 54-Week, Open Label, Multi-center Study to Assess the Long-Term Safety and Combination of Aliskiren 300 mg/Valsartan 320 mg in Patients with Essential Hypertension (Aliskiren 2301).” Principal Investigator: Marion R. Wofford Project Period: 07/01/2006-08/31/2008 Annual Funding: $102,755 Sponsor and Title: Novartis Pharmaceuticals, “A Multi-center, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 24 Weeks Treatment with Vildagliptin 100 mg qd or Metformin 1500 mg daily in Elderly Drug Naïve Patients with Type 2 Diabetes (CLAF).” Principal Investigator: Marion R. Wofford Project Period: 08/01/2006-08/31/2008 Annual Funding: $51,940 Sponsor and Title: Novartis Pharmaceuticals, “A 10-Week, Multi-center, Randomized, Double- Blind, Parallel-Group, Forced-Titration Study Using 24-Hr ABPM to Evaluate the Efficacy of a Valsartan/Hydrochlorothiazide (HCTZ) Treatment Regimen Versus Conventional Treatment Regimen with Amlodipine and Hydrochlorothiazide (HCTZ) in Patients with Stage 2 Hypertension (EVALUATE).” Principal Investigator: Marion R. Wofford Project Period: 11/08/2006-07/31/2008 Annual Funding: $29,400 Sponsor and Title: HHS, “Retaining African American Research Participation using a Community Driven Model” Principal Investigator: Sharon B. Wyatt Project Period: 10/01/2005-09/30/2006 Annual Funding: $44,999 Sponsor and Title: NIH, “Excellence in Partnerships for Community Outreach, Research on Health Disparities and Training” Principal Investigator: Sharon B. Wyatt Project Period: 9/1/2006-8/31/2007 Annual Funding: $25,000
Page 1 and 2:
U NIVERSITY OF M ISSISSIPPI M EDICA
Page 3 and 4:
Contents CHAIRMAN’S COMMENTS . .
Page 5 and 6:
2 The second annual Department of M
Page 7 and 8:
4 Mississippi Delta B. B. King. Pho
Page 9 and 10:
6 Delta Diabetes Project For Marsha
Page 11 and 12:
8 Poor Monkey’s is one of the Mis
Page 13 and 14:
10 Rheumatology Clinic With just ov
Page 15 and 16:
12 From left: Robert Clark, chairma
Page 17 and 18:
14 Jinna Shepherd The “Physician
Page 19 and 20:
16 Jim Wilson Population Studies an
Page 21 and 22:
18 Leandro Mena Infectious Success
Page 23 and 24:
20 Vince Herrin Providing Direction
Page 25 and 26:
22 Jim Wilson Mary Currier Populati
Page 27 and 28:
24 “Taking Requests”: Gary Patt
Page 29 and 30: 26 Matthew Cassell, MD PGY-II Kirk
Page 31 and 32: 28 David Letbetter, MD PGY-I David
Page 33 and 34: 30 Chris Abrasley, MD Digestive Dis
Page 35 and 36: 32 Olantunji Oluwatade, MD Infectio
Page 37 and 38: 34 Education Council Education rema
Page 39 and 40: 36 Clinical Council The Department
Page 41 and 42: 38 The Department of Medicine’s R
Page 43 and 44: 40 Administrative Council The missi
Page 45 and 46: 42 Executive Council The Executive
Page 47 and 48: FACULTY 44 Michael Winniford, MD Di
Page 49 and 50: FACULTY 46 Gailen Marshall, MD, PhD
Page 51 and 52: FACULTY Thomas L. Abell, MD, Profes
Page 53 and 54: FACULTY Christian A. Koch, MD, PhD,
Page 55 and 56: FACULTY Marion R. Wofford, MD, MPH,
Page 57 and 58: Mark Meeks, MD Division Director FA
Page 59 and 60: FACULTY Joe C. Files, MD, FACP, Pro
Page 61 and 62: FACULTY Stanley W. Chapman, MD, Pro
Page 63 and 64: FACULTY Michael F. Flessner, MD, Ph
Page 65 and 66: FACULTY J. Tate Thigpen, MD, Profes
Page 67 and 68: FACULTY G. Douglas Campbell, MD, Pr
Page 69 and 70: FACULTY Rob McMurray, MD Division D
Page 71 and 72: 68 “Janie”: Gary Patterson and
Page 73 and 74: 70 Sponsor and Title: HRSA, “The
Page 75 and 76: 72 Sponsor and Title: American Hear
Page 77 and 78: 74 Sponsor and Title: DHHS, “Hear
Page 79: 76 Sponsor and Title: NIDDK, “Gen
Page 83 and 84: 80 Ahmad N, Keith-Ferris J, Gooden
Page 85 and 86: 82 Garrett P, Brown CA, Hart-Hester
Page 87 and 88: 84 Lou XY, Ma JZ, Sun D, Payne TJ,
Page 89 and 90: 86 Riche DM, Valderrama R, Henyan N
Page 91 and 92: 88 “Just Married”: Gary Patters
Page 93 and 94: 90 Abell TL, Al-Juburi A, Lahr C, R
Page 95 and 96: 92 Alnabhan N, Penman A, Butler K,
Page 97 and 98: 94 Fox E, Benjamin E, Sarpong D, Wi
Page 99 and 100: 96 Keahey W, Walker E, Wyatt S, Wof
Page 101 and 102: 98 Ross L, Low A, Sumrall C, Bouldi
Page 103 and 104: 100 Ventura-Holman T, Mamoon A, Mah
show all

Fiscal Year 2007 - Department of Medicine - University of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?